Nrf2 (C-Term) Polyclonal Antibody
Nrf2 (C-Term) Polyclonal Antibody
Nuclear factor erythroid 2-related factor 2 (Nrf2) is a basic leucine zipper transcription factor encoded by NFE2L2 in humans that...
€474.00
ViewPrice:
From €66.00 €56.10
From €66.00 €56.10
Ramoplanin complex is a mixture of ramoplanin A1, -A2, and -A3 originally isolated from Actinoplanes that has antibacterial activity.{46853,46854,46855} Ramoplanin complex is active against clinical isolates of the Gram-positive bacteria S. aureus, S. pyogenes, S. pneumoniae, and S. faecalis (MICs = 0.016-2 µg/ml) but not Gram-negative bacteria or C. albicans (MICs = ?128 µg/ml).{46854} It inhibits cell wall synthesis in B. subtilis when used at a concentration of 0.5 µg/ml.{46853} Ramoplanin complex is effective against systemic S. pyogenes, S. pneumoniae, and S. aureus infections in mice with ED50 values of 0.081, 0.14, and approximately 25 mg/kg per day, respectively.
Territorial Availability: Available through Bertin Technologies only in France
| Size | 10 mg, 100 mg, 250 mg, 50 mg |
|---|---|
| Shipping | dry ice |
| CAS number | 76168-82-6 |
| Molecular formula | C119H154ClN21O40 (for A2) |
| Smiles | OC(C=C1)=CC=C1[C@H](C(N[C@H](CCCN)C(N[C@@]([C@H](O)C)([H])C(N[C@@H](C2=CC=C(O)C=C2)C(N[C@H](C3=CC=C(O)C=C3)C(NC([C@H](C)O)C(N[C@@H](CC4=CC=CC=C4)C(N[C@H](CCCN)C(N[C@@H](C5=CC=C(O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]6O[C@]7([H])[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O7)C=C5)C8=O)=O)=O)=O)=O)=O)=O)=O)=O)NC([C@@H](NC([C@@H](NC(/C=CC=CCCC)=O)CC(N)=O)=O)[C@@H](C(N)=O)OC([C@]([H])(C9=CC=C(O)C(Cl)=C9)NC([C@@H](C)NC([C@H](CC(C)C)NC(CNC([C@H](C=CC=C(O)C=C)NC([C@]([C@H](O)C)([H])N8)=O)=O)=O)=O)=O)=O)=O.OC(C=C)=CC=C[C@H](C(N[C@H](CCCN)C(N[C@@]([C@H](O)C)([H])C(N[C@@H](C=CC=C(O)C=C)C(N[C@H](C=CC=C(O)C=C)C(NC([C@H](C)O)C(N[C@@H](CC=CC=CC=C)C(N[C@H](CCCN)C(N[C@@H](C=CC=C(O[C@H]O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]O[C@]([H])[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O)C=C)C=O)=O)=O)=O)=O)=O)=O)=O)=O)NC([C@@H](NC([C@@H](NC(/C=CC=CCC(C)C)=O)CC(N)=O)=O)[C@@H](C(N)=O)OC([C@]([H])(C=CC=C(O)C(Cl)=C)NC([C@@H](C)NC([C@H](CC(C)C)NC(CNC([C@H](C=CC=C(O)C=C)NC([C@]([C@H](O)C)([H])N)=O)=O)=O)=O)=O)=O)=O.OC(C=C)=CC=C[C@H](C(N[C@H](CCCN)C(N[C@@]([C@H](O)C)([H])C(N[C@@H](C=CC=C(O)C=C)C(N[C@H](C=CC=C(O)C=C)C(NC([C@H](C)O)C(N[C@@H](CC=CC=CC=C)C(N[C@H](CCCN)C(N[C@@H](C=CC=C(O[C@H]O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]O[C@]([H])[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O)C=C)C=O)=O)=O)=O)=O)=O)=O)=O)=O)NC([C@@H](NC([C@@H](NC(/C=CC=CCCC(C)C)=O)CC(N)=O)=O)[C@@H](C(N)=O)OC([C@]([H])(C=CC=C(O)C(Cl)=C)NC([C@@H](C)NC([C@H](CC(C)C)NC(CNC([C@H](C=CC=C(O)C=C)NC([C@]([C@H](O)C)([H])N)=O)=O)=O)=O)=O)=O)=O, OC(C=C1)=CC=C1[C@H](C(N[C@H](CCCN)C(N[C@@]([C@H](O)C)([H])C(N[C@@H](C2=CC=C(O)C=C2)C(N[C@H](C3=CC=C(O)C=C3)C(NC([C@H](C)O)C(N[C@@H](CC4=CC=CC=C4)C(N[C@H](CCCN)C(N[C@@H](C5=CC=C(O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]6O[C@]7([H])[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O7)C=C5)C8=O)=O)=O)=O)=O)=O)=O)=O)=O)NC([C@@H](NC([C@@H](NC(/C=CC=CCCC)=O)CC(N)=O)=O)[C@@H](C(N)=O)OC([C@]([H])(C9=CC=C(O)C(Cl)=C9)NC([C@@H](C)NC([C@H](CC(C)C)NC(CNC([C@H](C=CC=C(O)C=C)NC([C@]([C@H](O)C)([H])N8)=O)=O)=O)=O)=O)=O)=O.OC(C=C)=CC=C[C@H](C(N[C@H](CCCN)C(N[C@@]([C@H](O)C)([H])C(N[C@@H](C=CC=C(O)C=C)C(N[C@H](C=CC=C(O)C=C)C(NC([C@H](C)O)C(N[C@@H](CC=CC=CC=C)C(N[C@H](CCCN)C(N[C@@H](C=CC=C(O[C@H]O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]O[C@]([H])[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O)C=C)C=O)=O)=O)=O)=O)=O)=O)=O)=O)NC([C@@H](NC([C@@H](NC(/C=CC=CCC(C)C)=O)CC(N)=O)=O)[C@@H](C(N)=O)OC([C@]([H])(C=CC=C(O)C(Cl)=C)NC([C@@H](C)NC([C@H](CC(C)C)NC(CNC([C@H](C=CC=C(O)C=C)NC([C@]([C@H](O)C)([H])N)=O)=O)=O)=O)=O)=O)=O.OC(C=C)=CC=C[C@H](C(N[C@H](CCCN)C(N[C@@]([C@H](O)C)([H])C(N[C@@H](C=CC=C(O)C=C)C(N[C@H](C=CC=C(O)C=C)C(NC([C@H](C)O)C(N[C@@H](CC=CC=CC=C)C(N[C@H](CCCN)C(N[C@@H](C=CC=C(O[C@H]O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]O[C@]([H])[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O)C=C)C=O)=O)=O)=O)=O)=O)=O)=O)=O)NC([C@@H](NC([C@@H](NC(/C=CC=CCCC(C)C)=O)CC(N)=O)=O)[C@@H](C(N)=O)OC([C@]([H])(C=CC=C(O)C(Cl)=C)NC([C@@H](C)NC([C@H](CC(C)C)NC(CNC([C@H](C=CC=C(O)C=C)NC([C@]([C@H](O)C)([H])N)=O)=O)=O)=O)=O)=O)=O, OC(C=C1)=CC=C1[C@H](C(N[C@H](CCCN)C(N[C@@]([C@H](O)C)([H])C(N[C@@H](C2=CC=C(O)C=C2)C(N[C@H](C3=CC=C(O)C=C3)C(NC([C@H](C)O)C(N[C@@H](CC4=CC=CC=C4)C(N[C@H](CCCN)C(N[C@@H](C5=CC=C(O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]6O[C@]7([H])[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O7)C=C5)C8=O)=O)=O)=O)=O)=O)=O)=O)=O)NC([C@@H](NC([C@@H](NC(/C=CC=CCCC)=O)CC(N)=O)=O)[C@@H](C(N)=O)OC([C@]([H])(C9=CC=C(O)C(Cl)=C9)NC([C@@H](C)NC([C@H](CC(C)C)NC(CNC([C@H](C=CC=C(O)C=C)NC([C@]([C@H](O)C)([H])N8)=O)=O)=O)=O)=O)=O)=O.OC(C=C)=CC=C[C@H](C(N[C@H](CCCN)C(N[C@@]([C@H](O)C)([H])C(N[C@@H](C=CC=C(O)C=C)C(N[C@H](C=CC=C(O)C=C)C(NC([C@H](C)O)C(N[C@@H](CC=CC=CC=C)C(N[C@H](CCCN)C(N[C@@H](C=CC=C(O[C@H]O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]O[C@]([H])[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O)C=C)C=O)=O)=O)=O)=O)=O)=O)=O)=O)NC([C@@H](NC([C@@H](NC(/C=CC=CCC(C)C)=O)CC(N)=O)=O)[C@@H](C(N)=O)OC([C@]([H])(C=CC=C(O)C(Cl)=C)NC([C@@H](C)NC([C@H](CC(C)C)NC(CNC([C@H](C=CC=C(O)C=C)NC([C@]([C@H](O)C)([H])N)=O)=O)=O)=O)=O)=O)=O.OC(C=C)=CC=C[C@H](C(N[C@H](CCCN)C(N[C@@]([C@H](O)C)([H])C(N[C@@H](C=CC=C(O)C=C)C(N[C@H](C=CC=C(O)C=C)C(NC([C@H](C)O)C(N[C@@H](CC=CC=CC=C)C(N[C@H](CCCN)C(N[C@@H](C=CC=C(O[C@H]O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]O[C@]([H])[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O)C=C)C=O)=O)=O)=O)=O)=O)=O)=O)=O)NC([C@@H](NC([C@@H](NC(/C=CC=CCCC(C)C)=O)CC(N)=O)=O)[C@@H](C(N)=O)OC([C@]([H])(C=CC=C(O)C(Cl)=C)NC([C@@H](C)NC([C@H](CC(C)C)NC(CNC([C@H](C=CC=C(O)C=C)NC([C@]([C@H](O)C)([H])N)=O)=O)=O)=O)=O)=O)=O, OC(C=C1)=CC=C1[C@H](C(N[C@H](CCCN)C(N[C@@]([C@H](O)C)([H])C(N[C@@H](C2=CC=C(O)C=C2)C(N[C@H](C3=CC=C(O)C=C3)C(NC([C@H](C)O)C(N[C@@H](CC4=CC=CC=C4)C(N[C@H](CCCN)C(N[C@@H](C5=CC=C(O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]6O[C@]7([H])[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O7)C=C5)C8=O)=O)=O)=O)=O)=O)=O)=O)=O)NC([C@@H](NC([C@@H](NC(/C=CC=CCCC)=O)CC(N)=O)=O)[C@@H](C(N)=O)OC([C@]([H])(C9=CC=C(O)C(Cl)=C9)NC([C@@H](C)NC([C@H](CC(C)C)NC(CNC([C@H](C=CC=C(O)C=C)NC([C@]([C@H](O)C)([H])N8)=O)=O)=O)=O)=O)=O)=O.OC(C=C)=CC=C[C@H](C(N[C@H](CCCN)C(N[C@@]([C@H](O)C)([H])C(N[C@@H](C=CC=C(O)C=C)C(N[C@H](C=CC=C(O)C=C)C(NC([C@H](C)O)C(N[C@@H](CC=CC=CC=C)C(N[C@H](CCCN)C(N[C@@H](C=CC=C(O[C@H]O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]O[C@]([H])[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O)C=C)C=O)=O)=O)=O)=O)=O)=O)=O)=O)NC([C@@H](NC([C@@H](NC(/C=CC=CCC(C)C)=O)CC(N)=O)=O)[C@@H](C(N)=O)OC([C@]([H])(C=CC=C(O)C(Cl)=C)NC([C@@H](C)NC([C@H](CC(C)C)NC(CNC([C@H](C=CC=C(O)C=C)NC([C@]([C@H](O)C)([H])N)=O)=O)=O)=O)=O)=O)=O.OC(C=C)=CC=C[C@H](C(N[C@H](CCCN)C(N[C@@]([C@H](O)C)([H])C(N[C@@H](C=CC=C(O)C=C)C(N[C@H](C=CC=C(O)C=C)C(NC([C@H](C)O)C(N[C@@H](CC=CC=CC=C)C(N[C@H](CCCN)C(N[C@@H](C=CC=C(O[C@H]O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]O[C@]([H])[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O)C=C)C=O)=O)=O)=O)=O)=O)=O)=O)=O)NC([C@@H](NC([C@@H](NC(/C=CC=CCCC(C)C)=O)CC(N)=O)=O)[C@@H](C(N)=O)OC([C@]([H])(C=CC=C(O)C(Cl)=C)NC([C@@H](C)NC([C@H](CC(C)C)NC(CNC([C@H](C=CC=C(O)C=C)NC([C@]([C@H](O)C)([H])N)=O)=O)=O)=O)=O)=O)=O |
| Molecular weight | 2554,1 |
| Custom code | 2941.90 |
| Formulation | A solid |
| Purity | ≥80% (Ramoplanin A2) |
| UNSPSC code | 12352100 |
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.
Nuclear factor erythroid 2-related factor 2 (Nrf2) is a basic leucine zipper transcription factor encoded by NFE2L2 in humans that...
Endocannabinoids, such as arachidonoyl ethanolamide (AEA) and 2-arachidonoyl glycerol (2-AG), function as short-range modulators of cell and synaptic activity. Monoacylglycerol...
24(S),25-epoxy Cholesterol is an oxysterol and the most abundant oxysterol in mouse ventral midbrain.{43943} It activates liver X receptors (LXRs)...
The Cayman COX Inhibitor Pack contains a combination of frequently used cyclooxygenase (COX) inhibitors. Each kit contains aspirin, the archetype...
Protein phosphorylation is an important post-translational modification that serves many key functions to regulate a protein’s activity, localization, and protein-protein...
This mixture contains primary prostaglandins produced from arachidonic acid and dihomo-?-linolenic acid. Contents: Prostaglandin E1, Prostaglandin E2, Prostaglandin F1?, 6-keto...
This mixture contains the primary COX products produced by most mammalian tissues. Contents: Prostaglandin D2, Prostaglandin E2, 6-keto Prostaglandin F1?,...
(+)-D-threo-PDMP is a ceramide analog and is one of the four possible stereoisomers of PDMP (Item No. 62595).{11392} (+)-D-threo-PDMP is...
Secretory phospholipase A2 (sPLA2) (Type IIA) is a calcium-dependent PLA2 superfamily member that is encoded by PLA2G2A in humans.{56210} It...
This mixture contains the characteristic metabolites of both PGI2 and TXA2. Contents: Thromboxane B2, 11-dehydro Thromboxane B2, 6-keto Prostaglandin F1?,...
This rabbit anti-mouse IgA FITC is used as the ‘secondary antibody’ for immunostaining experiments where the primary antibody is mouse...
Cytosolic PGE synthase (cPGES) is a glutathione-dependent enzyme with a predicted size of 18.6 kDa (23 kDa on SDS-PAGE). The...
GST-tag Polyclonal Antibody (FITC) is a probe for the immunochemical detection of GST tags on recombinant proteins. Recombinant proteins are...
Adenosine Receptor A2A is a multi-pass membrane protein that is normally localized to the plasma membrane.{15465} This receptor is part...
Proprotein convertase subtilisin kexin 9 (PCSK9) is a member of the subtilisin serine protease family with an important role in...
The cyclopentenone prostaglandin HPLC mixture contains all of the major UV-absorbing cyclopentenone prostaglandins and their precursors supplied in methyl acetate....
CD34 is a transmembrane phosphoglycoprotein and sialomucin protein that is commonly used as a marker for hematopoietic progenitor cells.{59706,59704} It...
GPR17 is a G protein-coupled receptor that has been identified as a dualistic receptor recognizing signals from two unrelated chemical...
Headquarters:
Parc d’activités du Pas du Lac
10 bis avenue Ampère
78180 Montigny le Bretonneux
France
Copyright © 2024 BERTIN BIOREAGENT. All rights reserved | Terms & conditions
